ACAD
38.21
+0.07
+0.18%
AEMD
0.21
+0.02
+10.34%
APRI
2.46
+0.07
+3.05%
ARNA
4.29
+0.25
+6.06%
ATEC
1.5
-0.02
-1.32%
CFN
60.27
+0.14
+0.23%
CNAT
6.28
-0.04
-0.63%
CRXM
0.2
+0.01
+5.83%
CYTX
1.13
-0.07
-5.83%
DXCM
60.04
+0.99
+1.68%
GNMK
12.68
-0.1
-0.78%
HALO
15.67
+0.44
+2.89%
ILMN
192.71
-3.32
-1.69%
INNV
0.17
-0.02
-10.81%
INO
7.37
+0.32
+4.54%
ISCO
0.06
+0.00
+1.72%
ISIS
70.27
+1.61
+2.35%
LGND
67.52
+1.07
+1.61%
LPTN
2.93
-0.02
-0.68%
MBVX
1
+0.07
+7.53%
MEIP
5.5
-0.24
-4.18%
MNOV
3.61
-0.03
-0.69%
MRTX
24.34
+0.79
+3.35%
MSTX
0.56
+0.04
+7.43%
NBIX
41.42
+0.56
+1.37%
NUVA
45.03
+0.77
+1.74%
ONCS
0.38
+0.01
+1.34%
ONVO
5.84
+0.04
+0.69%
OREX
8.62
+0.98
+12.83%
OTIC
36.74
-0.13
-0.35%
QDEL
26
+0.19
+0.74%
RCPT
128.07
+3.08
+2.46%
RGLS
18.48
+0.19
+1.04%
RMD
64.92
+0.43
+0.67%
SCIE
0.03
+0.01
+17.17%
SPHS
0.8
+0.09
+13.07%
SRNE
13.58
+0.38
+2.88%
TROV
6.35
-0.01
-0.16%
VICL
1.01
+0.02
+1.81%
VOLC
17.99
0.00
0.00%
ZGNX
1.69
+0.02
+1.20%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.